Skip to content
2000
Volume 20, Issue 1
  • ISSN: 1573-4056
  • E-ISSN: 1875-6603
side by side viewer icon HTML

Abstract

Introduction:

Molybdenum cofactor deficiency (MoCD-A) is an extremely rare autosomal recessive disease that presents with intractable seizures. The diagnosis poses challenges due to the limited number of cases reported worldwide. Magnetic resonance imaging (MRI) is a useful diagnostic tool that can detect brain injury associated with the disorder. The prognosis of MoCD-A is poor partly because most cases are initially misdiagnosed as HIE (hypoxic ischemic encephalopathy), emphasizing the need for an early and accurate diagnosis to improve quality of life and provide adequate genetic counseling to avoid new cases in the future.

Case Report:

This report presents a case of molybdenum cofactor deficiency type A (MoCD-A) caused by gene mutations. A male newborn was admitted on the 10th day of birth due to uncontrolled seizures and feeding difficulties. Brain MRI showed severe cerebral damage with multiple foci that did not enhance upon contrast administration. The diagnosis was confirmed by genetic analysis and the patient received rehabilitation. His parents also received genetic counseling. To the best of our knowledge, this is the first reported MoCD-A case that had enhanced MR imaging with Gd-DTPA (0.1 mmol/kg). In addition, we reviewed the clinical and neuroimaging features of 25 newborns diagnosed with MoCD-A, as documented in the existing literature.

Conclusion:

MRI is crucial in the diagnosis of MoCD-A. A correct diagnosis can provide the family with timely genetic counseling to prevent future cases.

This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International Public License (CC-BY 4.0), a copy of which is available at: https://creativecommons.org/licenses/by/4.0/legalcode. This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Loading

Article metrics loading...

/content/journals/cmir/10.2174/0115734056259160231106075042
2023-12-12
2025-10-15
Loading full text...

Full text loading...

/deliver/fulltext/cmir/20/1/e15734056259160.html?itemId=/content/journals/cmir/10.2174/0115734056259160231106075042&mimeType=html&fmt=ahah

References

  1. MechlerK. MountfordW.K. HoffmannG.F. RiesM. Ultra-orphan diseases: A quantitative analysis of the natural history of molybdenum cofactor deficiency.Genet. Med.2015171296597010.1038/gim.2015.1225764214
    [Google Scholar]
  2. HuijmansJ.G.M. SchotR. de KlerkJ.B.C. WilliamsM. de CooR.F.M. DuranM. VerheijenF.W. van SlegtenhorstM. ManciniG.M.S. Molybdenum cofactor deficiency: Identification of a patient with homozygote mutation in the MOCS3 gene.Am. J. Med. Genet. A.201717361601160610.1002/ajmg.a.3824028544736
    [Google Scholar]
  3. ReissJ. Molybdenum cofactor and sulfite oxidase deficiency.Metabolomics20166318410.4172/2153‑0769.1000184
    [Google Scholar]
  4. NagappaM. BinduP.S. TalyA.B. SinhaS. BharathR.D. Child Neurology: Molybdenum cofactor deficiency.Neurology20158523e175e17810.1212/WNL.000000000000219426644055
    [Google Scholar]
  5. FathallaW. MohamedK. AhmedE. Molybdenum cofactor deficiency: Report of a new case and literature review.Ibnosina J Med Biomed Sci20102313313810.4103/1947‑489X.210984
    [Google Scholar]
  6. ArenasM. FairbanksL.D. VijayakumarK. CarrL. EscuredoE. MarinakiA.M. An unusual genetic variant in the MOCS1 gene leads to complete missplicing of an alternatively spliced exon in a patient with molybdenum cofactor deficiency.J. Inherit. Metab. Dis.200932456056910.1007/s10545‑009‑1151‑719544009
    [Google Scholar]
  7. ZhangX. VincentA.S. HalliwellB. WongK.P. A mechanism of sulfite neurotoxicity: Direct inhibition of glutamate dehydrogenase.J. Biol. Chem.200427941430354304510.1074/jbc.M40275920015273247
    [Google Scholar]
  8. HinderhoferK. MechlerK. HoffmannG.F. LampertA. MountfordW.K. RiesM. Critical appraisal of genotype assessment in molybdenum cofactor deficiency.J. Inherit. Metab. Dis.201740680181110.1007/s10545‑017‑0077‑828900816
    [Google Scholar]
  9. WuL-H. JiangY. HuY. [Molybdenum cofactor deficiency caused by MOCS1 gene mutation: A case report].Zhongguo Dang Dai Er Ke Za Zhi202123441641933840416
    [Google Scholar]
  10. Alonzo MartínezM.C. CazorlaE. CánovasE. AnniukK. CoresA.E. SerranoA.M. Molybdenum cofactor deficiency: Mega cisterna magna in two consecutive pregnancies and review of the literature.Appl. Clin. Genet.2020131495510.2147/TACG.S23991732099439
    [Google Scholar]
  11. MayrS.J. SassJ.O. VryJ. KirschnerJ. MaderI. HövenerJ.B. ReissJ. Santamaria-AraujoJ.A. SchwarzG. GrünertS.C. A mild case of molybdenum cofactor deficiency defines an alternative route of MOCS1 protein maturation.J. Inherit. Metab. Dis.201841218719610.1007/s10545‑018‑0138‑729368224
    [Google Scholar]
  12. VeldmanA. Santamaria-AraujoJ.A. SollazzoS. PittJ. GianelloR. Yaplito-LeeJ. WongF. RamsdenC.A. ReissJ. CookI. FairweatherJ. SchwarzG. Successful treatment of molybdenum cofactor deficiency type A with cPMP.Pediatrics20101255e1249e125410.1542/peds.2009‑219220385644
    [Google Scholar]
  13. KibeT. HasegawaH. IchidaK. KoshimizuE. MiyatakeS. MatsumotoN. YokochiK. YoshimuraA. The persistent generalized muscle contraction in siblings with molybdenum cofactor deficiency type A.Neuropediatrics201950212612910.1055/s‑0039‑167786930695801
    [Google Scholar]
  14. ZakiM.S. SelimL. EL-BassyouniH.T. IssaM.Y. MahmoudI. IsmailS. GirgisM. SadekA.A. GleesonJ.G. Abdel HamidM.S. Molybdenum cofactor and isolated sulphite oxidase deficiencies: Clinical and molecular spectrum among Egyptian patients.Eur. J. Paediatr. Neurol.201620571472210.1016/j.ejpn.2016.05.01127289259
    [Google Scholar]
  15. VijayakumarK. GunnyR. GrunewaldS. CarrL. ChongK.W. DeVileC. RobinsonR. McSweeneyN. PrabhakarP. Clinical neuroimaging features and outcome in molybdenum cofactor deficiency.Pediatr. Neurol.201145424625210.1016/j.pediatrneurol.2011.06.00621907887
    [Google Scholar]
  16. HiguchiR. SugimotoT. TamuraA. KiokaN. TsunoY. HigaA. YoshikawaN. Early features in neuroimaging of two siblings with molybdenum cofactor deficiency.Pediatrics20141331e267e27110.1542/peds.2013‑093524379235
    [Google Scholar]
  17. MacayaA. BrunsoL. Fernández-CastilloN. ArranzJ.A. GinjaarH.B. Cuenca-LeónE. CorominasR. RoigM. CormandB. Molybdenum cofactor deficiency presenting as neonatal hyperekplexia: A clinical, biochemical and genetic study.Neuropediatrics200536638939410.1055/s‑2005‑87287716429380
    [Google Scholar]
  18. SchwahnB.C. Van SpronsenF.J. BelaidiA.A. BowhayS. ChristodoulouJ. DerksT.G. HennermannJ.B. JamesonE. KönigK. McGregorT.L. Font-MontgomeryE. Santamaria-AraujoJ.A. SantraS. VaidyaM. VierzigA. WassmerE. WeisI. WongF.Y. VeldmanA. SchwarzG. Efficacy and safety of cyclic pyranopterin monophosphate substitution in severe molybdenum cofactor deficiency type A: A prospective cohort study.Lancet2015386100071955196310.1016/S0140‑6736(15)00124‑526343839
    [Google Scholar]
  19. SassJ.O. GunduzA. Araujo Rodrigues FunayamaC. KorkmazB. Dantas PintoK.G. TuysuzB. Yanasse Dos SantosL. TaskiranE. de Fátima TurcatoM. LamC.W. ReissJ. WalterM. YalcinkayaC. Camelo JuniorJ.S. Functional deficiencies of sulfite oxidase: Differential diagnoses in neonates presenting with intractable seizures and cystic encephalomalacia.Brain Dev.201032754454910.1016/j.braindev.2009.09.00519793632
    [Google Scholar]
  20. Carmi-NawiN. MalingerG. MandelH. IchidaK. Lerman-SagieT. LevD. Prenatal brain disruption in molybdenum cofactor deficiency.J. Child Neurol.201126446046410.1177/088307381038301721285035
    [Google Scholar]
  21. GümüşH. GhesquiereS. PerH. KondolotM. IchidaK. PoyrazoğluG. KumandaşS. EngelenJ. DundarM. ÇağlayanA.O. Maternal uniparental isodisomy is responsible for serious molybdenum cofactor deficiency.Dev. Med. Child Neurol.201052986887210.1111/j.1469‑8749.2010.03724.x20573177
    [Google Scholar]
  22. IchidaK. Ibrahim AydinH. HosoyamadaM. KalkanogluH.S. DursunA. OhnoI. CoskunT. TokatliA. ShibasakiT. HosoyaT. A Turkish case with molybdenum cofactor deficiency.Nucleosides Nucleotides Nucleic Acids2006259-111087109110.1080/1525777060089402217065069
    [Google Scholar]
  23. AbeY AiharaY EndoW The effect of dietary protein restriction in a case of molybdenum cofactor deficiency with MOCS1 mutation.Mol Genet Metab Rep.20212610071610.1016/j.ymgmr.2021.100716
    [Google Scholar]
  24. BayramE. TopcuY. KarakayaP. YisU. CakmakciH. IchidaK. KurulS.H. Molybdenum cofactor deficiency: Review of 12 cases (MoCD and review).Eur. J. Paediatr. Neurol.20131711610.1016/j.ejpn.2012.10.00323122324
    [Google Scholar]
  25. LuboutC.M.A. DerksT.G.J. MeinersL. ErwichJ.J. BergmanK.A. LunsingR.J. SchwarzG. VeldmanA. van SpronsenF.J. Molybdenum cofactor deficiency type A: Prenatal monitoring using MRI.Eur. J. Paediatr. Neurol.201822353654010.1016/j.ejpn.2017.11.00629274890
    [Google Scholar]
  26. KingsmoreS.F. RamchandarN. JamesK. NiemiA.K. FeigenbaumA. DingY. BensonW. HobbsC. NahasS. ChowdhuryS. DimmockD. Mortality in a neonate with molybdenum cofactor deficiency illustrates the need for a comprehensive rapid precision medicine system.Molecular Case Studies202061a00470510.1101/mcs.a00470532014857
    [Google Scholar]
/content/journals/cmir/10.2174/0115734056259160231106075042
Loading
/content/journals/cmir/10.2174/0115734056259160231106075042
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test